Since thyroid cancer survivors tend to be on TSH suppression therapy, hence they typically have higher thyroid hormone level than counterparts; this may unexpectedly lead to decreased incidence of colorectal cancer. This evidence concerns the gene TG and thyroid gland carcinoma.